ATE359066T1 - Pflaster mit 4-biphenylessigsäure - Google Patents
Pflaster mit 4-biphenylessigsäureInfo
- Publication number
- ATE359066T1 ATE359066T1 AT01934446T AT01934446T ATE359066T1 AT E359066 T1 ATE359066 T1 AT E359066T1 AT 01934446 T AT01934446 T AT 01934446T AT 01934446 T AT01934446 T AT 01934446T AT E359066 T1 ATE359066 T1 AT E359066T1
- Authority
- AT
- Austria
- Prior art keywords
- weight
- biphenylacetic acid
- plaster
- biphenylacetic
- styrene
- Prior art date
Links
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 title abstract 4
- 239000011505 plaster Substances 0.000 title abstract 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 abstract 2
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 206010040880 Skin irritation Diseases 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 230000001760 anti-analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 abstract 1
- 230000036556 skin irritation Effects 0.000 abstract 1
- 231100000475 skin irritation Toxicity 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000164496A JP4648518B2 (ja) | 2000-06-01 | 2000-06-01 | 4−ビフェニル酢酸含有貼付剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE359066T1 true ATE359066T1 (de) | 2007-05-15 |
Family
ID=18668107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01934446T ATE359066T1 (de) | 2000-06-01 | 2001-05-31 | Pflaster mit 4-biphenylessigsäure |
Country Status (13)
Country | Link |
---|---|
US (1) | US7094421B2 (de) |
EP (1) | EP1300143B1 (de) |
JP (1) | JP4648518B2 (de) |
KR (1) | KR100721748B1 (de) |
CN (1) | CN1170530C (de) |
AT (1) | ATE359066T1 (de) |
AU (1) | AU775131B2 (de) |
CA (1) | CA2380128C (de) |
DE (1) | DE60127839T2 (de) |
DK (1) | DK1300143T3 (de) |
ES (1) | ES2280371T3 (de) |
TW (1) | TW577737B (de) |
WO (1) | WO2001091743A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1611884B1 (de) | 2003-03-18 | 2012-11-14 | Hisamitsu Pharmaceutical Co., Inc. | Pflaster mit diclofenac |
EP1711170B1 (de) * | 2004-01-14 | 2009-07-29 | Lavipharm Laboratories, Inc. | Transdermale abgabevorrichtung für dihydropyridin-artige calcium-antagonisten mit 2 fettsäuren |
EP1854460B1 (de) * | 2005-02-28 | 2016-10-05 | Teikoku Seiyaku Co., Ltd. | Äusserliches pflaster mit flurbiprofen |
CN1989955B (zh) * | 2005-12-29 | 2010-12-15 | 北京德众万全医药科技有限公司 | 联苯乙酸巴布剂 |
JP5078303B2 (ja) * | 2006-09-15 | 2012-11-21 | 東光薬品工業株式会社 | 消炎鎮痛クリーム製剤及びその製造方法 |
JP4879928B2 (ja) | 2008-03-25 | 2012-02-22 | 帝國製薬株式会社 | ケトプロフェンリジン塩を含有する水性貼付剤 |
JP5564241B2 (ja) | 2009-12-15 | 2014-07-30 | 帝國製薬株式会社 | フェルビナク含有経皮吸収製剤 |
EP2636405B1 (de) * | 2010-11-02 | 2018-03-14 | Teikoku Seiyaku Co., Ltd. | Felbinachaltiges hautpflaster |
CN110693859A (zh) * | 2012-06-20 | 2020-01-17 | 美德阿利克斯株式会社 | 通过掺混药物、有机溶剂、亲脂性基质和粉末获得的粘附制剂组合物 |
CN110114064A (zh) | 2016-12-28 | 2019-08-09 | 久光制药株式会社 | 贴剂 |
US11872320B2 (en) | 2021-02-25 | 2024-01-16 | Hisamitsu Pharmaceutical Co., Inc. | Method for treating osteoarthritis |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5719197A (en) * | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5262165A (en) * | 1992-02-04 | 1993-11-16 | Schering Corporation | Transdermal nitroglycerin patch with penetration enhancers |
JP2839164B2 (ja) * | 1989-12-25 | 1998-12-16 | 帝國製薬株式会社 | 消炎鎮痛貼付剤 |
JP3723229B2 (ja) * | 1991-03-12 | 2005-12-07 | 武田薬品工業株式会社 | 外用貼付剤 |
JP3541849B2 (ja) | 1991-04-19 | 2004-07-14 | 久光製薬株式会社 | 消炎鎮痛貼付剤 |
FR2717689B1 (fr) * | 1994-03-28 | 1996-07-05 | Lhd Lab Hygiene Dietetique | Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base de copolymère styrène-isoprène-styrène. |
PT781553E (pt) * | 1994-09-16 | 2008-04-09 | Hisamitsu Pharmaceutical Co | Penso para uso externo |
JP3496169B2 (ja) * | 1994-10-17 | 2004-02-09 | 大協薬品工業株式会社 | 硬膏剤及びその製造法 |
KR100525610B1 (ko) * | 1996-12-06 | 2005-11-02 | 히사미쓰 세이야꾸 가부시키가이샤 | 펠비나크 함유 점착제 |
JPH10218793A (ja) * | 1997-02-03 | 1998-08-18 | Nichiban Co Ltd | 経皮吸収型消炎鎮痛用テープ剤及びその製造方法 |
JPH10316560A (ja) * | 1997-05-21 | 1998-12-02 | Toko Yakuhin Kogyo Kk | 貼付剤 |
JP3665473B2 (ja) * | 1998-04-28 | 2005-06-29 | 東芝ソリューション株式会社 | 書類データ処理管理システム |
-
2000
- 2000-06-01 JP JP2000164496A patent/JP4648518B2/ja not_active Expired - Fee Related
-
2001
- 2001-05-31 ES ES01934446T patent/ES2280371T3/es not_active Expired - Lifetime
- 2001-05-31 KR KR1020027001037A patent/KR100721748B1/ko not_active IP Right Cessation
- 2001-05-31 WO PCT/JP2001/004583 patent/WO2001091743A1/ja active IP Right Grant
- 2001-05-31 DK DK01934446T patent/DK1300143T3/da active
- 2001-05-31 AU AU60673/01A patent/AU775131B2/en not_active Ceased
- 2001-05-31 AT AT01934446T patent/ATE359066T1/de not_active IP Right Cessation
- 2001-05-31 CA CA002380128A patent/CA2380128C/en not_active Expired - Fee Related
- 2001-05-31 DE DE60127839T patent/DE60127839T2/de not_active Expired - Lifetime
- 2001-05-31 US US10/048,402 patent/US7094421B2/en not_active Expired - Lifetime
- 2001-05-31 TW TW090113184A patent/TW577737B/zh not_active IP Right Cessation
- 2001-05-31 CN CNB018014852A patent/CN1170530C/zh not_active Expired - Fee Related
- 2001-05-31 EP EP01934446A patent/EP1300143B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20020173736A1 (en) | 2002-11-21 |
TW577737B (en) | 2004-03-01 |
CA2380128C (en) | 2009-07-07 |
AU6067301A (en) | 2001-12-11 |
KR20020015388A (ko) | 2002-02-27 |
WO2001091743A1 (fr) | 2001-12-06 |
EP1300143A4 (de) | 2005-12-07 |
EP1300143B1 (de) | 2007-04-11 |
DE60127839D1 (de) | 2007-05-24 |
DK1300143T3 (da) | 2007-07-09 |
CN1380830A (zh) | 2002-11-20 |
EP1300143A1 (de) | 2003-04-09 |
JP4648518B2 (ja) | 2011-03-09 |
KR100721748B1 (ko) | 2007-05-25 |
ES2280371T3 (es) | 2007-09-16 |
CA2380128A1 (en) | 2001-12-06 |
AU775131B2 (en) | 2004-07-15 |
JP2001342130A (ja) | 2001-12-11 |
US7094421B2 (en) | 2006-08-22 |
CN1170530C (zh) | 2004-10-13 |
DE60127839T2 (de) | 2008-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69902875D1 (de) | Tts enthaltend ein antioxidans | |
NO20001567D0 (no) | Bioadhesive sammensetninger og fremgangsmåter for topisk administrering av aktive midler | |
TR199901417T2 (xx) | Analjezik etkisi olan yeni bile�imler. | |
DE60027463D1 (de) | Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon | |
BR0108435A (pt) | Formulação e uso de entecavir de baixa dose | |
CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
BR0108584A (pt) | Formulações contendo um fármaco anticolinérgico para o tratamento da broncopneumopatia crÈnica obtrutiva | |
ATE517614T1 (de) | Pflaster enthaltend einen anti-inflammatorischen wirkstoff | |
NO20043871L (no) | Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid | |
DE60127839D1 (de) | Pflaster mit 4-biphenylessigsäure | |
BR0007294A (pt) | Formulações farmacêuticas aperfeiçoadas | |
ES2146227T3 (es) | Composiciones farmaceuticas que contienen nifedipina y procedimiento para su preparacion. | |
RS50768B (sr) | Režim doziranja i farmaceutska formulacija za urgentnu zaštitu | |
DE60019334D1 (de) | Antivirale arznei | |
DK1069902T3 (da) | Anvendelse af phospholipider til fremstilling af et lægemiddel til forebyggelse af adhæsioner | |
ATE464878T1 (de) | Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl | |
EP0647616A4 (de) | Zink-tranexamat derivat. | |
TR200200473T2 (tr) | Rar selektif retinoid agonistleri. | |
DK0693926T3 (da) | Ny farmaceutisk sammensætning til fremstilling af et stabilt pulver indeholdende en kombination af acetylsalicylsyre og metoclopramid som aktiv bestanddel. | |
JPS56161323A (en) | Anti-inflammatory and pain-killing gel | |
DE50010973D1 (de) | Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus | |
SE9902742D0 (sv) | New pharmaceutical formultion | |
HK1029277A1 (en) | Pharmaceutical coating composition and method of use. | |
IT1291895B1 (it) | Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo | |
DK1691805T3 (da) | Anvendelse af urocansyre som er i stand til at omdanne celle cytoplasm til syre |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |